It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In this study, we examined the difference in the vaginal microbiota of women infected with human papillomavirus (HPV), according to menopausal status. A total of 75 cervicovaginal swab samples from 38 pre- and 37 postmenopausal women with HPV infection were obtained from the Korean HPV cohort. Vaginal microbiota analysis, including microbial diversity and specific bacterial abundances, was performed using 16S rRNA gene sequencing. The mean age of the pre- and postmenopausal women were 29.5 and 55.8 years, respectively (p < 0.0001). Lactobacillus spp. were predominant in both groups; however, a marked decrease was observed in postmenopausal women compared to premenopausal women (44.3% vs. 74.2%). Various anaerobic bacteria also showed a relatively high abundance in the postmenopausal group; Atopobium vagina and Gardnerella vaginalis significantly increased in postmenopausal women. Interestingly, no significant differences in bacterial richness were observed between the two groups. However, significant differences in beta-diversity were observed using the Bray–Curtis (p = 0.001), Generalized UniFrac (p = 0.002), Jensen-Shannon (p = 0.001), and UniFrac algorithms (p = 0.002). Theres results indicate that postmenopausal women with HPV infection exhibited a higher degree of vaginal dysbiosis than premenopausal women. Further, HPV-infected postmenopausal women had increased vaginal microbial diversity, characterized by an increase in anaerobic bacteria and concomitant depletion of Lactobacillus spp.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Konkuk University School of Medicine, Department of Obstetrics and Gynecology, Seoul, Republic of Korea (GRID:grid.258676.8) (ISNI:0000 0004 0532 8339)
2 The Catholic University, Department of Obstetrics and Gynecology, Seoul St. Mary’s Hospital, Seoul, Republic of Korea (GRID:grid.414966.8) (ISNI:0000 0004 0647 5752)
3 Keimyung University Dongsan Medical Center, Department of Obstetrics and Gynecology, Daegu, Republic of Korea (GRID:grid.414067.0) (ISNI:0000 0004 0647 8419)
4 Korea University, Department of Obstetrics and Gynecology, College of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
5 CHA University College of Medicine, Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, Seoul, Republic of Korea (GRID:grid.410886.3) (ISNI:0000 0004 0647 3511)
6 Inje University College of Medicine, Department of Obstetrics and Gynecology, Busan Paik Hospital, Busan, Republic of Korea (GRID:grid.411612.1) (ISNI:0000 0004 0470 5112)
7 Graduate School of Cancer Science and Policy, Department of Cancer Control and Population Health, National Cancer Center, Goyang, Republic of Korea (GRID:grid.410914.9) (ISNI:0000 0004 0628 9810)